STRYKER CORP Deferred Tax Liabilities, Gross
STRYKER CORP (SYK) had Deferred Tax Liabilities, Gross of $1.36 billion as of 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-11
- 2025-12-31: Deferred Tax Liabilities, Gross $1.36B.
- 2024-12-31: Deferred Tax Liabilities, Gross $1.20B.
- 2023-12-31: Deferred Tax Liabilities, Gross $1.06B.
- 2022-12-31: Deferred Tax Liabilities, Gross $1.08B.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $1.36B 10-K · filed 2026-02-11 |
| 2024-12-31 | $1.20B 10-K · filed 2026-02-11 |
| 2023-12-31 | $1.06B 10-K · filed 2025-02-12 |
| 2022-12-31 | $1.08B 10-K · filed 2024-02-14 |
| 2021-12-31 | $1.00B 10-K · filed 2023-02-10 |
| 2020-12-31 | $1.45B 10-K · filed 2022-02-11 |
| 2019-12-31 | $930.00M 10-K · filed 2021-02-11 |
| 2018-12-31 | $914.00M 10-K · filed 2020-02-06 |
| 2017-12-31 | $682.00M 10-K · filed 2019-02-07 |
| 2016-12-31 | $971.00M 10-K · filed 2018-02-08 |
| 2015-12-31 | $662.00M 10-K · filed 2017-02-09 |
| 2014-12-31 | $852.00M 10-K · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |